Countries with prevalence rates of hepatitis B greater than or equal to 8% are considered by the WHO to be high endemic countries, and the WHO recommends introducing the hepatitis B vaccine in these countries’ routine immunization programs [1]. This evidence concerns the gene PPIB and Hepatitis.